Welcome to our dedicated page for XEBRA BRANDS news (Ticker: XBRAF), a resource for investors and traders seeking the latest updates and insights on XEBRA BRANDS stock.
XEBRA Brands Ltd. is a leading cannabis company that focuses on providing high-quality CBD products to consumers globally. The company recently signed a manufacturing agreement with Restorative Botanicals, marking a significant milestone as it expands its product portfolio. This collaboration will introduce premium CBD tinctures to the Mexican market, with products crafted to meet XEBRA's specifications. The company aims to manufacture locally in Mexico in the future but is currently importing products to meet consumer demands. XEBRA's commitment to quality and innovation is highlighted through its collaboration with Restorative Botanicals, a renowned provider of premium CBD products.
Xebra Brands Ltd. (CSE: XBRA, OTCQB: XBRAF) has received a court extension from the Mexican Health Regulatory Agency (COFEPRIS) to grant cannabis authorizations, now expected by the week of February 6. These authorizations will focus on cannabis with low levels of THC, primarily for hemp products and CBD sales. The company also announces significant management changes, including the resignation of founder Robert Giustra as Chairman to pursue mining ventures, along with CFO Andrew Yau and Corporate Secretary Daniela Freitas. Rodrigo Gallardo is appointed as the interim CFO and Corporate Secretary.
Xebra Brands Ltd. (CSE: XBRA, OTCQB: XBRAF) announces a favorable ruling from a District Court regarding cannabis authorizations in Mexico. The court dismissed a resolution by COFEPRIS, the Mexican health regulatory agency, as insufficient. It ordered COFEPRIS to issue full authorizations within three business days, although delays are anticipated due to holiday closures. The authorizations will apply to low-THC cannabis, focusing on hemp cultivation and CBD products, with potential opportunities in hemp plastics.
Xebra Brands Ltd. (CSE: XBRA, OTCQB: XBRAF) has announced progress regarding cannabis authorizations in Mexico. The Mexican Health Regulatory Agency, COFEPRIS, has notified Xebra Mexico that it has complied with a Supreme Court mandate for cannabis authorizations. However, Xebra asserts that COFEPRIS has not fully met this mandate and has sought federal judicial intervention. The authorizations will mainly pertain to low-THC cannabis (under 1%) for hemp cultivation and CBD products. Delays in the authorization process are anticipated due to the lack of legal precedent in Mexico.
Xebra Brands Ltd. (CSE: XBRA, OTCQB: XBRAF) has announced that its cannabis-infused beverage, Vicious Citrus OG, is performing exceptionally in Ontario's cannabis market, which features over 1,300 retailers. Launched in August 2022, it is currently the best-selling non-carbonated lemonade and ranks in the top 20% of all cannabis beverage SKUs in Ontario. The company plans to expand the brand to British Columbia, Alberta, and Manitoba and considers international opportunities. CEO Jay Garnett noted positive feedback from consumers and budtenders.
Xebra Brands Ltd. (CSE: XBRA) (OTCQB: XBRAF) has provided an update on cannabis authorizations for its Mexican subsidiary, Xebra Mexico. Following a court order, the Mexican Health Regulatory Agency (COFEPRIS) is expected to issue authorizations for the importation, cultivation, and processing of cannabis products, specifically those with low THC levels. These authorizations mark a precedent in Mexico’s cannabis landscape. Xebra is positioned to tap into opportunities in hemp and CBD products, with potential expansion in hemp plastics.
FAQ
What is the current stock price of XEBRA BRANDS (XBRAF)?
What is the market cap of XEBRA BRANDS (XBRAF)?
What is XEBRA Brands Ltd. focused on?
What recent milestone did XEBRA achieve?
What is the goal of the collaboration with Restorative Botanicals?
How does XEBRA plan to manufacture products in the future?
What highlights XEBRA's commitment to quality and innovation?
